Lavipharm S.A (LAVI) — Cash Flow Reinvestment Rate

Latest as of December 2022: 33.32x

Lavipharm S.A (LAVI) has a Cash Flow Reinvestment Rate of 33.32x as of December 2022, reinvesting €17.56 Million (capex €17.56 Million ) from operating cash flow of €527.00K. Explore how much does Lavipharm S.A reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

33.32x
(Capex + Investments) / Operating CF

Total Reinvested

€17.56 Million
Capex + Investments

Operating Cash Flow

€527.00K
EUR

Capital Expenditures

€17.56 Million
EUR

Lavipharm S.A Cash Flow Reinvestment Rate (2014–2024)

Historical reinvestment intensity for Lavipharm S.A across 11 annual periods. Also explore Lavipharm S.A (LAVI) total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Lavipharm S.A (2014–2024)

Year-by-year capital reinvestment analysis for Lavipharm S.A. For live market cap and broader valuation context, see Lavipharm S.A stock valuation.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2024 4.13x €19.14 Million €4.64 Million €9.64 Million ▼ -84.4%
2023 26.43x €7.51 Million €284.00K €4.05 Million ▲ +24.2%
2022 21.28x €71.21 Million €3.35 Million €35.62 Million ▲ +2038.2%
2021 1.00x €3.80 Million €3.82 Million €1.92 Million ▼ -3.8%
2020 1.03x €2.95 Million €2.85 Million €1.48 Million ▲ +23.9%
2019 0.84x €2.42 Million €2.89 Million €2.42 Million ▲ +14.7%
2018 0.73x €1.03 Million €1.42 Million €1.03 Million ▲ +215.0%
2017 0.23x €350.00K €1.51 Million €350.00K ▲ +25.1%
2016 0.18x €112.00K €606.00K €97.00K ▲ +180.1%
2015 0.07x €38.00K €576.00K €23.00K ▼ -87.1%
2014 0.51x €1.22 Million €2.38 Million €1.20 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow